Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation.
about
Thrombin activation and liver inflammation in advanced hepatitis C virus infectionCurrent and future disease progression of the chronic HCV population in the United States.PAI-1 4G-4G and MTHFR 677TT in non-hepatitis C virus/hepatitis B virus-related liver cirrhosis.Role of anticoagulant therapy in liver disease.Silymarin decreases connective tissue growth factor to improve liver fibrosis in rats treated with carbon tetrachloride.
P2860
Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Increased fibrosis progression ...... prothrombin G20210A mutation.
@ast
Increased fibrosis progression ...... prothrombin G20210A mutation.
@en
type
label
Increased fibrosis progression ...... prothrombin G20210A mutation.
@ast
Increased fibrosis progression ...... prothrombin G20210A mutation.
@en
prefLabel
Increased fibrosis progression ...... prothrombin G20210A mutation.
@ast
Increased fibrosis progression ...... prothrombin G20210A mutation.
@en
P2093
P2860
P356
P1476
Increased fibrosis progression ...... prothrombin G20210A mutation.
@en
P2093
Hava Peretz
Moshe Leshno
Nitsan Maharshak
Philippe Halfon
Shira Zelber-Sagi
Shlomo Berliner
Sigal Fishman
Uri Rozovski
Varda Deutsch
P2860
P304
P356
10.3748/WJG.V17.I45.5007
P407
P577
2011-12-01T00:00:00Z